Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Chikungunya Virus Infection: full-pipeline trial registry
A small indexed set (5 trials) with no open enrollment listed right now.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · none currently recruiting · #3,391 of 28,707 conditions by registered trial count
Chikungunya Virus Infection: 5 US clinical trials tracked, none currently recruiting.
Chikungunya Virus Infection is the subject of 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 2 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Bavarian Nordic, running 2 of these trials.
Enrollment posture brief
Registry condition chikungunya-virus-infection
OPEN 0 | RECR 0% | LATE 2 | EARLY 3 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Chikungunya Virus Infection has no open enrollment in this registry pull (5 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Chikungunya Virus Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Chikungunya Virus Infection is recruiting below its size-band peers.
0 of 5 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Chikungunya Virus Infection research.
Bavarian Nordic accounts for 2 of 5 trials (40%). 3 distinct sponsors appear on at least one study for this condition label.
-
Typical Chikungunya Virus Infection enrolment sits around 363 participants.
Median target enrolment is 363 among the 5 trials that report a genuine target (sentinel values excluded). 1 of those (20%) plan for fewer than 100 participants.
-
Chikungunya Virus Infection research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination
Bavarian Nordic
NCT06007183
Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553)
Valneva Austria
NCT04838444
Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults
Bavarian Nordic
NCT03483961
Phase I Trial of Measles Vectored Chikungungya Vaccine
National Institute of Allergy and Infectious Diseases (NIAID)
NCT03028441
Phase 1 Study of SAR440894 vs Placebo
National Institute of Allergy and Infectious Diseases (NIAID)
NCT04441905
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Chikungunya Virus Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Chikungunya Virus Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Chikungunya Virus Infection page
5 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Chikungunya Virus Infection trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Bavarian Nordic sponsors the most Chikungunya Virus Infection trials on record, review their full trial history before evaluating a specific study. See Bavarian Nordic's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chikungunya Virus Infection condition card totals 5 registered trials; most-linked intervention Placebo; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.